MAPS Statement on Bipartisan Congressional Letter to FDA

Washington DC — Reps. Jack Bergman (R-MI) and Lou Correa (D-CA), co-chairs of the Congressional Psychedelics Advancing Therapies Caucus, led a bipartisan group of 30 members of Congress in a letter to Food and Drug Administration (FDA) Commissioner Martin A. Makary, urging the agency to advance evaluation of psychedelic-assisted therapies. The letter asks FDA to… Continue reading MAPS Statement on Bipartisan Congressional Letter to FDA